Joel John Rutta*

Department of Sciences, Mathematics and Education, St. Joseph University in Tanzania, Tanzania

*Corresponding Author: Joel John Rutta, Department of Sciences, Mathematics and Education, St. Joseph University in Tanzania, Tanzania.

Received: November 25, 2025; Published: December 31, 2025

Abstract

Exosomes, nanoscale extracellular vesicles, have transitioned from being perceived as cellular debris to being recognized as pivotal mediators of intercellular communication and promising therapeutic agents. This review aimed to synthesize global advancements in exosome therapeutics, analyze the associated translational challenges, and evaluate the specific potential for integrating this technology within Tanzania's biomedical research and healthcare framework. This review utilized peer-reviewed literature from PubMed and Google Scholar, complemented by grey literature including regulatory agency reports and Tanzanian health policy documents, to provide a comprehensive systematic analysis. Studies were selected based on their focus on exosome biology, therapeutic applications (drug delivery, regenerative medicine, diagnostics), manufacturing challenges, regulatory considerations, and/or biomedical research capacity building in low-resource settings. The analysis confirms the significant therapeutic potential of exosomes but highlights major hurdles in standardization, manufacturing, and regulation. For Tanzania, key opportunities include developing exosome-based diagnostics for endemic diseases and leveraging international collaborations, while primary challenges encompass infrastructural deficits and a shortage of specialized expertise. We posit that with strategic investment, exosome technology represents a viable avenue for Tanzanian researchers to engage with cutting-edge biomedicine and develop context-specific solutions to public health challenges.

Keywords: Exosomes; Extracellular Vesicles; Therapeutics; Drug Delivery; Precision Medicine; Global Health; Tanzania; Biomedical Research; Capacity Building

References

1. Satheeshan G., et al. “Exosome theranostics: Comparative analysis of P body and exosome proteins and their mutations for clinical applications”. Functional and Integrative Genomics4 (2024): 124.
2. Batrakova EV and Kim MS. “Using exosomes, naturally-equipped nanocarriers, for drug delivery”. Journal of Controlled Release 219 (2015): 396-405.
3. Kim MS., et al. “Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells”. Nanomedicine: Nanotechnology, Biology and Medicine3 (2016): 655-664.
4. Doyle L and Wang M. “Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis”. Cells7 (2019): 727.
5. Gor H and Nema V. “Exosomes and Extracellular vesicles, potential tools in the effective management of tuberculosis infection”. The Microbe 8 (2025): 100520.
6. Manoochehri H., et al. “Extracellular Vesicles in Cancer Immunotherapy: Therapeutic, Challenges and Clinical Progress”. Asian Journal of Pharmaceutical Sciences (2025): 101065.
7. Sharma V and Mukhopadhyay CD. “Exosome as drug delivery system: Current advancements”. Extracell Vesicle 3 (2024): 100032.
8. Liang Y., et al. “Engineering exosomes for targeted drug delivery”. Theranostics7 (2021): 3183-3195.
9. de Jong B., et al. “Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine”. Pharmaceutics 11 (2020): 1006.
10. Carnino JM., et al. “Extracellular Vesicles: A Novel Opportunity for Precision Medicine in Respiratory Diseases”. Frontiers in Medicine 8 (2021): 661679.
11. Omrani M., et al. “Global trend in exosome isolation and application: an update concept in management of diseases”. Molecular and Cellular Biochemistry3 (2024): 679-691.
12. “Health Sector Strategic Plan July 2021-June 2026 (HSSP V)”. (2021).
13. Yi Zhang and Jiayao Bi. “Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications” (2021).
14. Barzin M., et al. “Application of plant-derived exosome-like nanoparticles in drug delivery”. Pharmaceutical Development and Technology5 (2023): 383-402.
15. Zhang M., et al. “Engineered exosomes from different sources for cancer-targeted therapy”. Signal Transduction and Targeted Therapy 1 (2023): 124.
16. Yu D., et al. “Exosomes as a new frontier of cancer liquid biopsy”. Molecular Cancer1 (2022): 56.
17. Li MY., et al. “Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis”. Molecular Cancer1 (2021): 22.
18. Szwedowicz U., et al. “Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology”. Molecules 4 (2022): 1303.
19. Odehnalová N., et al. “The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer”. Frontiers in Medicine 12 (2025): 1539714.
20. Muthu S., et al. “Exosomal therapy—a new frontier in regenerative medicine”. Stem Cell Investigation 8 (2021): 7.
21. Adelipour M., et al. “Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine”. Expert Opinion on Biological Therapy6 (2023): 491-507.
22. Popowski K., et al. “Exosome therapeutics for lung regenerative medicine”. Journal of Extracell Vesicles 2 9.1 (2020): 1785161.
23. Rezabakhsh A., et al. “Applications, challenges and prospects of mesenchymal stem cell exosomes in regenerative medicine”. Stem Cell Research Therapy1 (2021): 521.
24. Huda MN and Nurunnabi M. “Potential Application of Exosomes in Vaccine Development and Delivery”. Pharm Research11 (2022): 2635-2671.
25. Schorey JS and Harding CV. “Extracellular vesicles and infectious diseases: new complexity to an old story”. Journal of Clinical Investigation4 (2020): 1181-1189.
26. Feng J., et al. “Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19)”. Journal of Biomedical Nanotechnology4 (2020): 399-418.
27. Lee KWA., et al. “Clinical Applications of Exosomes: A Critical Review”. International Journal of Molecular Sciences14 (2024): 7794.
28. Chen YF., et al. “Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials”. Journal of Biomedical Sciences1 (2024): 67.
29. Zhou B., et al. “Application of exosomes as liquid biopsy in clinical diagnosis”. Signal Transduction and Targeted Therapy 1 (2020): 144.
30. Maja Petkovic. “Exosomes: A Promising New Tool for Diagnostic and Clinical Applications”. Amsbio (2020).
31. Delshad M., et al. “Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders”. Biomolecules4 (2022): 587.
32. Ahn SH., et al. “Manufacturing Therapeutic Exosomes: from Bench to Industry”. Molecular Cells5 (2024): 284-290.
33. Whitford W and Guterstam P. “Exosome Manufacturing Status”. Future Medicinal Chemistry10 (2019): 1225-1236.
34. Zhao X., et al. “Scalable and cost-effective CAR-T exosome therapies: challenges and future directions”. Immunotherapy12 (2025): 891-898.
35. Yadav A., et al. “Standardized Reporting of Research on Exosomes to Ensure Rigor and Reproducibility”. Advance in Wound Care11 (2024): 584-599.
36. Nelson BC., et al. “Measurement and Standardization Challenges for Extracellular Vesicle Therapeutic Delivery Vectors”. Nanomedicine22 (2020): 2149-2170.
37. Lai JJ., et al. “Exosome Processing and Characterization Approaches for Research and Technology Development”. Advance in Science15 (2022): 2103222.
38. Ludwig N., et al. “Challenges in Exosome Isolation and Analysis in Health and Disease”. International Journal of Molecular Science19 (2019): 4684.
39. Tang YT., et al. “Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum”. International Journal of Molecular Medicine3 (2017): 834-844.
40. Chen H and Li Q. “Recent advances in scalable exosome production: Challenges and innovations”. Chinese Journal of Plastic and Reconstructive Surgery 3 (2025): 149-163.
41. Escudero-Cernuda S., et al. “Limitations and challenges in the characterization of extracellular vesicles from stem cells and serum”. Microchime Acta5 (2025): 311.
42. Wang CK., et al. “Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes”. Clinical and Translational Science8 (2025): e13904.
43. Verma N and Arora S. “Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions”. Pharmaceutics 8 (2025): 990.
44. Li Q., et al. “Exploring Regulatory Frameworks for Exosome Therapy: Insights and Perspectives”. Health Care Science4 (2025): 299-309.
45. Ilgın Kımız Geboloğlu. “Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake”. (2022).
46. Serrano DR., et al. “Exosome-Based Drug Delivery: A Next-Generation Platform for Cancer, Infection, Neurological and Immunological Diseases, Gene Therapy and Regenerative Medicine”. Pharmaceutics 10 (2025): 1336.
47. Hussen BM., et al. “Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy”. Cancer Cell International1 (2018): 323.
48. Palakurthi SS., et al. “A comprehensive review of challenges and advances in exosome-based drug delivery systems”. Nanoscale Advances23 (2024): 5803-5826.
49. Xiao-Ming Xi XMX., et al. “Drug loading techniques for exosome-based drug delivery systems”. Pharmazie 2/3 (2021): 61-67.

Citation

Citation: Joel John Rutta. “Exosome Therapeutics: Global Advances and Strategic Implications for Biomedical Research in Tanzania".Acta Scientific Microbiology 9.1 (2026): 57-64.

Copyright

Copyright: © 2026 Joel John Rutta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.